Skip to main content

Cepheid, DxS Expand Scorpions License to Include Diagnostics

NEW YORK, Nov. 29 (GenomeWeb News) - Cepheid has licensed DxS' real-time PCR technology for use in the human in vitro diagnostics market, the company said today.

 

Cepheid originally licensed the probe technology, called Scorpions, in July for all markets except clinical diagnostics, wine production, and the detection of chemicals used in agriculture.

 

Cepheid said the product could be applicable to its SmartCycler and GeneXpert systems.

 

Financial details were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.